title: Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?
abstract: OBJECTIVE
  Insulin receptor substrate (IRS) proteins are critical to signal transduction in insulin target tissues. The present study was undertaken to determine whether IRS-1 Gly972Arg and IRS-2 Gly1057Asp influence hormonal and metabolic characteristics in Greek patients with polycystic ovary syndrome (PCOS) and controls.
  
  
  METHODS
  One hundred and eighty-three women with PCOS and 88 healthy volunteers were enrolled. Venous blood samples were obtained for genetic study and hormonal profile, glucose, and insulin assays, on days 3 to 7 from cycling patients. DNA was extracted by whole blood samples for genotyping and detection of IRS-1 Gly972Arg and IRS-2 Gly1057Asp polymorphisms.
  
  
  RESULTS
  Fifty-six women with PCOS (30.60%), whereas 12 women in the control group (13.64%) carried the IRS-1 polymorphism (p = 0.0026). No statistically significant differences in genotypes or allele frequencies for IRS-2 polymorphism were observed between controls and PCOS women. No significant differences in any clinical or hormonal measures between subjects on the basis of genotype were observed, except the increased levels of fasting glucose that exhibit the carriers of the Asp allele of the IRS-2 polymorphism.
  
  
  CONCLUSIONS
  Only the IRS-1 polymorphism is associated with increased susceptibility to PCOS in a Greek population. These loci should not be considered as major contributors to the hormonal and metabolic phenotype of PCOS.
authors.affiliation: Division of Pediatric-Adolescent Gynecology and Reconstructive Surgery, 2nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Athens, Greece. dr_christopoulos@yahoo.gr
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Christopoulos
authors.forename: George
authors.initials: G
authors.lastname: Mastorakos
authors.forename: Maria
authors.initials: M
authors.lastname: Gazouli
authors.forename: Efthymios
authors.initials: E
authors.lastname: Deligeoroglou
authors.forename: Ilias
authors.initials: I
authors.lastname: Katsikis
authors.forename: Evanthia
authors.initials: E
authors.lastname: Diamanti-Kandarakis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Panidis
authors.forename: George
authors.initials: G
authors.lastname: Creatsas
mesh_terms: D000328:Adult; D019943:Amino Acid Substitution / Q000235:genetics / Q000502:physiology; D001120:Arginine / Q000235:genetics; D001224:Aspartic Acid / Q000235:genetics; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D005998:Glycine / Q000235:genetics; D006115:Greece; D006801:Humans; D055504:Insulin Receptor Substrate Proteins / Q000235:genetics*; D011085:Polycystic Ovary Syndrome / Q000235:genetics* / Q000378:metabolism*; D011110:Polymorphism, Genetic / Q000502:physiology; D055815:Young Adult
chemical_list: C526292:IRS1 protein, human; C526297:IRS2 protein, human; D055504:Insulin Receptor Substrate Proteins; D001224:Aspartic Acid; D001120:Arginine; D005998:Glycine